Amyris, a California-based company focused on wellness products, said it has closed a deal potentially worth $300 million with biotech startup Lavvan to research and develop synthetic cannabinoids. The move follows that of Canada\u2019s Cronos Group inking a $122 million deal with Boston-based Ginkgo Bioworks\u00a0last September to produce lab-grown cannabinoids. Analysts at Toronto-based Paradigm Capital [\u2026]<\/p>\n
Amyris closes on potential $300M cannabinoid deal with biotech group Lavvan<\/a> is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n
Amyris, a California-based company focused on wellness products, said it has closed a deal potentially worth $300 million with biotech startup Lavvan to research and develop synthetic cannabinoids. The move follows that of Canada\u2019s Cronos Group inking a $122 million deal with Boston-based Ginkgo Bioworks\u00a0last September to produce lab-grown cannabinoids.Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":303,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4,28,9125,50,960,2786,139,195],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/33732"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/303"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=33732"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/33732\/revisions"}],"predecessor-version":[{"id":33733,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/33732\/revisions\/33733"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=33732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=33732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=33732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n
\nRead More: Amyris closes on potential 0M cannabinoid deal with biotech group Lavvan<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"